Eczema, atopy and allergen exposure in adults: A population-based study

Clinical and Experimental Allergy

Volumn 37, Issue 4, 2007, Pages 526-535

  Harrop, J ^a   Chinn, S ^b   Verlato, G ^c   Olivieri, M ^c   Norback D ^d   Wjst, M ^e   Janson, C ^d   Zock, J P ^f   Leynaert, B ^g   Gislason, D ^h   Ponzio, M ⁱ   Villani, S ⁱ   Carosso, A ^j   Svanes, C ^k   Heinrich, J ^e   Jarvis, D ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c UNIVERSITY OF VERONA   (Italy)

^d UPPSALA UNIVERSITY   (Sweden)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

^f INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^g INSERM   (France)

^h LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

ⁱ UNIVERSITY OF PAVIA   (Italy)

^j ASL 4   (Italy)

^k HAUKELAND UNIVERSITY HOSPITAL   (Norway)

more..

Author keywords

Atopic dermatitis; ECRHS; Eczema; Epidemiology

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4;

ADULT; AGE DISTRIBUTION; ARTICLE; ATOPY; CAT; CLADOSPORIUM; CONTROLLED STUDY; DEMOGRAPHY; DERMATOPHAGOIDES; ECZEMA; EUROPE; EXPOSURE; FAMILY HISTORY; FEMALE; GEOGRAPHICAL VARIATION (SPECIES); HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SAMPLE SIZE; SENSITIZATION; SEX DIFFERENCE; SIBLING; UNITED STATES;

ADULT; ALLERGENS; ANTIGENS, DERMATOPHAGOIDES; DERMATITIS, ATOPIC; ECZEMA; ENVIRONMENTAL EXPOSURE; EUROPE; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PREVALENCE;

EID: 34047226589     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2007.02679.x     Document Type: Article

References (42)

1. Johansson SG, Bieber T, Dahl R et al. Revised nomenclature for allergy for global use: report of the nomenclature review committee of the world allergy organization, October 2003. J Allergy Clin Immunol 2004; 113:832-6.
2. Williams H, Robertson C, Stewart A et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 1999; 103:125-38.
3. Wuthrich B. Clinical aspects, epidemiology, and prognosis of atopic dermatitis. Ann Allergy Asthma Immunol 1999; 83:464-70.
4. Williams HC. Atopic dermatitis - the epidemiology, causes, and prevention of atopic eczema. Cambridge, UK: Cambridge University Press, 2000.
5. Zutavern A, Hirsch T, Leupold W, Weiland S, Keil U, von Mutius E. Atopic dermatitis, extrinsic atopic dermatitis and the hygiene hypothesis: results from a cross-sectional study. Clin Exp Allergy 2005; 35:1301-8.
6. Gupta R, Sheikh A, Strachan DP, Anderson HR. Burden of allergic disease in the UK: secondary analyses of national databases. Clin Exp Allergy 2004; 34:520-6.
7. Rea JN, Newhouse ML, Halil T. Skin disease in Lambeth. A community study of prevalence and use of medical care. Br J Prev Soc Med 1976; 30:107-14.
8. Plunkett A, Merlin K, Gill D, Zuo Y, Jolley D, Marks R. The frequency of common nonmalignant skin conditions in adults in central Victoria, Australia. Int J Dermatol 1999; 38:901-8.
9. Montnemery P, Nihlen U, Goran LC, Nyberg P, Svensson A. Prevalence of self-reported eczema in relation to living environment, socio-economic status and respiratory symptoms assessed in a questionnaire study. BMC Dermatol 2003; 3:4.
10. Wolkenstein P, Grob JJ, Bastuji-Garin S, Ruszczynski S, Roujeau JC, Revuz J. French people and skin diseases: results of a survey using a representative sample. Arch Dermatol 2003; 139:1614-9.
11. Naldi L, Colombo P, PraKtis Study Center et al. Study design and preliminary results from the pilot phase of the PraKtis study: self-reported diagnoses of selected skin diseases in a representative sample of the Italian population. Dermatology 2004; 208:38-42.
12. Burney PG, Luczynska C, Chinn S, Jarvis D. The European Community Respiratory Health Survey. Eur Respir J 1994; 7:954-60.
13. European Community Respiratory Health Survey II Steering Committee. The European Community Respiratory Health Survey II. Eur Respir J 2002; 20:1071-9.
14. Luczynska CM, Arruda LK, Platts-Mills TA, Miller JD, Lopez M, Chapman MD. A two-site monoclonal antibody ELISA for the quantification of the major Dermatophagoides spp. allergens, Der p I and Der f I. J Immunol Methods 1989; 118:227-35.
15. Williams HC, Burney PG, Hay RJ et al. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 1994; 131:383-96.
16. International Labour Office G. International standard classification of occupations (ISCO-88). Geneva: International Labour Office, 1990.
17. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials 1986; 7:177-88.
18. STATACorporation. STATA 9.0. TX, USA: STATA Corporation, 2005.
19. Popescu CM, Popescu R, Williams H, Forsea D. Community validation of the United Kingdom diagnostic criteria for atopic dermatitis in Romanian schoolchildren. Br J Dermatol 1998; 138:436-42.
20. Haileamlak A, Lewis S, Britton J et al. Validation of the international study of asthma and allergies in children (ISAAC) and the UK criteria for atopic eczema in Ethiopian children. Epidemiol Health Serv Res 2004; 152:735-41.
21. Anonymous. Prevalence, morbidity, and cost of dermatological diseases. J Invest Dermatol 1979; 73:395-401.
22. Flohr C, Johansson SG, Wahlgren CF, Williams H. How atopic is atopic dermatitis? J Allergy Clin Immunol 2004; 114:150-8.
23. Karmaus W, Botezan C. Does a higher number of siblings protect against the development of allergy and asthma? A review. J Epidemiol Commun Health 2002; 56:209-17.
24. Montnemery P, Nihlen U, Goran LC, Nyberg P, Svensson A. Prevalence of self-reported eczema in relation to living environment, socio-economic status and respiratory symptoms assessed in a questionnaire study. BMC Dermatol 2003; 3:4.
25. Yemaneberhan H, Flohr C, Lewis SA et al. Prevalence and associated factors of atopic dermatitis symptoms in rural and urban Ethiopia. Clin Exp Allergy 2004; 34:779-85.
26. Miyake Y, Miyamoto S, Ohya Y et al. Association of active and passive smoking with allergic disorders in pregnant Japanese women: baseline data from the Osaka Maternal and Child Health Study. Ann Allergy Asthma Immunol 2005; 94:644-51.
27. Tariq SM, Matthews SM, Stevens M, Hakim EA. Sensitization to Alternaria and Cladosporium by the age of 4 years. Clin Exp Allergy 1996; 26:794-8.
28. Schafer T, Heinrich J, Wjst M, Adam H, Ring J, Wichmann HE. Association between severity of atopic eczema and degree of sensitization to aeroallergens in schoolchildren. J Allergy Clin Immunol 1999; 104:1280-4.
29. Reijula K, Leino M, Mussalo-Rauhamaa H et al. IgE-mediated allergy to fungal allergens in Finland with special reference to Alternaria alternata and Cladosporium herbarum. [see comment]. Ann Allergy Asthma Immunol 2003; 91:280-7.
30. Colloff MJ. Exposure to house dust mites in homes of people with atopic dermatitis. Br J Dermatol 1992; 127:322-7.
31. Harving H, Korsgaard J, Dahl R, Beck HI, Bjerring P. House dust mites and atopic dermatitis. A case-control study on the significance of house dust mites as etiologic allergens in atopic dermatitis. Ann Allergy 1990; 65:25-31.
32. Beck HI, Korsgaard J. Atopic dermatitis and house dust mites. Br J Dermatol 1989; 120:245-51.
33. Hansen SK, Deleuran M, Johnke H, Thestrup-Pedersen K. House dust mite antigen exposure of patients with atopic dermatitis of psoriasis. Acta Derm Venereol 1998; 78:139-41.
34. Kramer U, Lemmen C, Bartusel E, Link E, Ring J, Behrendt H. Current eczema in children is related to Der f 1 exposure but not to Der p 1 exposure. Br J Dermatol 2006; 154:99-105.
35. Schafer T, Vieluf D, Behrendt H, Kramer U, Ring J. Atopic eczema and other manifestations of atopy: results of a study in East and West Germany. Allergy 1996; 51:532-9.
36. Kilpelainen M, Terho EO, Helenius H, Koskenvuo M. Home dampness, current allergic diseases, and respiratory infections among young adults. Thorax 2001; 56:462-7.
37. Bornehag CG, Sundell J, Hagerhed-Engman L, Sigsggard T, Janson S, Aberg N. 'Dampness' at home and its association with airway, nose, and skin symptoms among 10 851 preschool children in Sweden: a cross-sectional study. Indoor Air 2005; 15 (Suppl. 10):48-55.
38. Simoni M, Lombardi E, Berti G et al. Mould/dampness exposure at home is associated with respiratory disorders in Italian children and adolescents: the SIDRIA-2 Study. Occup Environ Med 2005; 62:616-22.
39. Shakib F, McLaughlan P, Stanworth DR, Smith E, Fairburn E. Elevated serum IgE and IgG4 in patients with atopic dermatitis. Br J Dermatol 1977; 97:59-63.
40. Merrett J, Barnetson RS, Burr ML, Merrett TG. Total and specific IgG4 antibody levels in atopic eczema. Clin Exp Immunol 1984; 56:645-52.
41. Rowntree S, Platts-Mills TA, Cogswell JJ, Mitchell EB. A subclass IgG4-specific antigen-binding radioimmunoassay (RIA): comparison between IgG and IgG4 antibodies to food and inhaled antigens in adult atopic dermatitis after desensitization treatment and during development of antibody responses in children. J Allergy Clin Immunol 1987; 80:622-30.
42. Carneiro R, Reefer A, Wilson B et al. T cell epitope-specific defects in the immune response to cat allergen in patients with atopic dermatitis. J Invest Dermatol 2004; 122:927-36.